Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Wang Q, Qin X, Fang J, et al. Nanomedicines for the treatment of rheumatoid arthritis: state of art and potential therapeutic strategies. Acta Pharmaceutica Sinica B. 2021;11(5):1158–1174. doi:10.1016/j.apsb.2021.03.013
   PubMed Web of Science ®Google Scholar
• Cascão R, Vidal B, Raquel H, et al. Potent anti-inflammatory and antiproliferative effects of gambogic acid in a rat model of antigen-induced arthritis. Mediators Inflamm. 2014;2014:195327. doi:10.1155/2014/195327
   PubMed Web of Science ®Google Scholar
• Wu X, Long L, Liu J, et al. Gambogic acid suppresses inflammation in rheumatoid arthritis rats via PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 2017;16(5):7112–7118. doi:10.3892/mmr.2017.7459
   PubMed Web of Science ®Google Scholar
• Rahman M, Beg S, Verma A, et al. Phytoconstituents as pharmacotherapeutics in rheumatoid arthritis: challenges and scope of nano/submicromedicine in its effective delivery. J Pharm Pharmacol. 2017;69(1):1–14. doi:10.1111/jphp.12661
   PubMed Web of Science ®Google Scholar
• Nguyen A, Ando H, Böttger R, et al. Utilization of click chemistry to study the effect of poly(ethylene)glycol molecular weight on the self-assembly of PEGylated gambogic acid nanoparticles for the treatment of rheumatoid arthritis. Biomater Sci. 2020;8(16):4626–4637. doi:10.1039/D0BM00711K
   PubMed Web of Science ®Google Scholar
• Hatami E, Jaggi M, Chauhan SC, et al. Gambogic acid: a shining natural compound to nanomedicine for cancer therapeutics. Biochim Biophys Acta. 2020;1874(1):188381. doi:10.1016/j.bbcan.2020.188381
   PubMed Web of Science ®Google Scholar
• Karaosmanoglu S, Zhou M, Shi B, et al. Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release. 2021;329:805–832. doi:10.1016/j.jconrel.2020.10.014
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen Y, Lin L, et al. Gambogic acid as a candidate for cancer therapy: a review. Int J Nanomedicine. 2020;15:10385–10399. doi:10.2147/IJN.S277645
   PubMed Web of Science ®Google Scholar
• Liu R, Luo C, Pang Z, et al. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chin Chem Letters. 2023;34(2):107518. doi:10.1016/j.cclet.2022.05.032
   Web of Science ®Google Scholar
• Xin Li J, Jiao Zhang M, Feng Shi J, et al. pH-sensitive nano-polyelectrolyte complexes with arthritic macrophage-targeting delivery of triptolide. Int J Pharm. 2023;632:122572. doi:10.1016/j.ijpharm.2022.122572
   PubMedGoogle Scholar
• Zhao J, Chen X, Ho K-H, et al. Nanotechnology for diagnosis and therapy of rheumatoid arthritis: evolution towards theranostic approaches. Chin Chem Letters. 2021;32(1):66–86. doi:10.1016/j.cclet.2020.11.048
   Web of Science ®Google Scholar
• Zhang X, Li N, Zhang S, et al. Emerging carrier-free nanosystems based on molecular self-assembly of pure drugs for cancer therapy. Med Res Rev. 2020;40(5):1754–1775. doi:10.1002/med.21669
   PubMed Web of Science ®Google Scholar
• Li S, Shan X, Wang Y, et al. Dimeric prodrug-based nanomedicines for cancer therapy. J Control Release. 2020;326:510–522. doi:10.1016/j.jconrel.2020.07.036
   PubMed Web of Science ®Google Scholar
• Fu S, Li G, Zang W, et al. Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharmaceutica Sinica B. 2022;12(1):92–106. doi:10.1016/j.apsb.2021.08.012
   PubMed Web of Science ®Google Scholar
• Deng C, Zhang Q, He P, et al. Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nat Commun. 2021;12(1):2174. doi:10.1038/s41467-021-22454-z
   PubMed Web of Science ®Google Scholar
• Shi J, Ren Y, Ma J, et al. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis. J Nanobiotechnology. 2021;19(1):188. doi:10.1186/s12951-021-00934-0
   PubMed Web of Science ®Google Scholar
• Xu Y, Mu J, Xu Z, et al. Modular acid-activatable acetone-based ketal-linked nanomedicine by dexamethasone prodrugs for enhanced anti-rheumatoid arthritis with low side effects. Nano Lett. 2020;20(4):2558–2568. doi:10.1021/acs.nanolett.9b05340
   PubMed Web of Science ®Google Scholar
• Nguyen A, Rouhollahi E, Böttger R, et al. Interplay between the linker and polymer molecular weight of a self-assembling prodrug on the pharmacokinetics and therapeutic efficacy. Biomater Sci. 2022;10(12):3122–3136. doi:10.1039/D1BM01947C
   PubMed Web of Science ®Google Scholar
• Wang X, Yang B, Li L, et al. Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies. Theranostics. 2021;11(16):7896–7910. doi:10.7150/thno.61337
   PubMed Web of Science ®Google Scholar
• Wang L, Pu X, Nie X, et al. Integrated serum pharmacochemistry and network pharmacological analysis used to explore possible anti-rheumatoid arthritis mechanisms of the Shentong-Zhuyu decoction. J Ethnopharmacol. 2021;273:113988. doi:10.1016/j.jep.2021.113988
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu M, Pei R. An in situ gelling BMSC-laden collagen/silk fibroin double network hydrogel for cartilage regeneration. Mater Adv. 2021;2(14):4733–4742. doi:10.1039/D1MA00285F
   Google Scholar
• Siouti E, Andreakos E. The many facets of macrophages in rheumatoid arthritis. Biochem Pharmacol. 2019;165:152–169. doi:10.1016/j.bcp.2019.03.029
   PubMed Web of Science ®Google Scholar
• Szentpétery Á, Horváth Á, Gulyás K, et al. Effects of targeted therapies on the bone in arthritides. Autoimmun Rev. 2017;16(3):313–320. doi:10.1016/j.autrev.2017.01.014
   PubMed Web of Science ®Google Scholar
• Dickerson TJ, Suzuki E, Stanecki C, et al. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. J Autoimmun. 2012;39(4):369–376. doi:10.1016/j.jaut.2012.06.001
   PubMed Web of Science ®Google Scholar
• Liu Y, Jin J, Xu H, et al. Construction of a pH-responsive, ultralow-dose triptolide nanomedicine for safe rheumatoid arthritis therapy. Acta biomaterialia. 2021;121:541–553. doi:10.1016/j.actbio.2020.11.027
   PubMed Web of Science ®Google Scholar
• Wang Q, Jiang H, Li Y, et al. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 2017;122:10–22. doi:10.1016/j.biomaterials.2017.01.008
   PubMed Web of Science ®Google Scholar
• Li C, Li H, Wang Q, et al. pH-sensitive polymeric micelles for targeted delivery to inflamed joints. J Control Release. 2017;246:133–141. doi:10.1016/j.jconrel.2016.12.027
   PubMed Web of Science ®Google Scholar